Golden Green, Inc. Leap Therapeutics, Inc. Transaction History

Golden Green, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$1.6 - $3.35 $23,718 - $49,660	-14,824 Closed	0 $0
Q2 2021 Jul 14, 2021	SELL	$1.48 - $1.92 $9,076 - $11,775	-6,133 Reduced 29.26%	14,824 $24,000
Q1 2021 Apr 13, 2021	SELL	$1.82 - $3.01 $88,493 - $146,355	-48,623 Reduced 69.88%	20,957 $40,000
Q4 2020 Jan 25, 2021	BUY	$1.49 - $2.37 $103,674 - $164,904	69,580 New	69,580 $157,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $288M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.